相关实验视频
Updated: Sep 13, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
532
对于食道癌的同时化学放射治疗中有毒副作用和预后因素的模式
ZiLong Feng1, MengLi Li1, Bo Cui1
1Department of Tumor Radiotherapy, Gongyi People's Hospital, Zhengzhou, China.
概括
局部控制失败和复发是食道癌患者同时接受化学放射治疗 (CCRT) 的主要死亡原因. 较短的瘤和早期阶段可以提高生存率,强调需要精确的治疗和毒性管理.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 辐射疗法 辐射疗法
背景情况:
- 食道癌症是一个重大的全球健康挑战,死亡率和复发率很高.
- 同时化疗放射治疗 (CCRT) 是一种标准治疗,但了解其结果和毒性至关重要.
研究的目的:
- 在接受CCRT的食道癌症患者中系统评估死亡原因和治疗毒性.
- 确定影响生存结果的关键预后因素.
主要方法:
- 79名食道癌患者的临床数据的回顾性分析.
- 评估CCRT后的生存率,毒性副作用和主要死亡原因.
主要成果:
- 当地控制失败和复发是导致死亡的主要原因.
- 1,2,3年和4年的总生存率分别为82.3%,50.9%,42.3%和40.0% (中位生存时间:13个月).
- 放射性食管炎和恶心/吐是常见的毒性;瘤的长度和临床阶段是显著的预后因素.
结论:
- 优化CCRT策略需要专注于早期诊断,精确的局部控制和有效的毒性管理.
- 改善生存率和生活质量取决于有效处理复发和转移.
- 研究结果为改善食道癌治疗患者治疗结果提供了实际指导.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
305
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
305
Barrett Esophagus-I: Introduction
210
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
210
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
322
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
322
Esophageal Varices-II: Clinical Features and Management
144
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
144
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Esophageal Strictures-I: Introduction
269
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
269

